MTI Staff was not involved in writing this content NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. ...
The global market for Artificial Intelligence For Drug Development and Discovery Market has witnessed rapid growth, escalating from a valuation of $520 million in 2019 to a projected $4,815 million by ...
The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to ...
Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss ...
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submission of ...
The global AI in healthcare market has witnessed an exponential growth trajectory, with its valuation surging from $4,836.87 million in 2019 to a projected $99,491.58 million by 2027. T his report ...
Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...
"Our team showed agility and resourcefulness, working with our clinical research partners to execute our clinical study plan and analyze the data ... transport and logistics firms, drug treatment ...
Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties ...
A self-administered test can help empower women in identifying risks for cervical cancer.A new study published Dec. 1 ...